(CRDO) Credo Technology Holding - Ratings and Ratios
Electrical Cables, Optical DSPs, PHY Chips, SerDes IP, PCIe Retimers
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 82.6% |
| Value at Risk 5%th | 129% |
| Relative Tail Risk | -5.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.20 |
| Alpha | 68.93 |
| CAGR/Max DD | 1.99 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.477 |
| Beta | 2.795 |
| Beta Downside | 2.801 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.04% |
| Mean DD | 17.56% |
| Median DD | 13.08% |
Description: CRDO Credo Technology Holding December 17, 2025
Credo Technology Group Holding Ltd (NASDAQ:CRDO) designs and sells high-speed connectivity solutions-including active electrical HiWire cables, optical PAM4 DSPs, low-power line-card PHYs, and SerDes chiplets/IP-for Ethernet and PCIe markets across the U.S., Taiwan, Mainland China, Hong Kong, and globally. Its product portfolio also covers predictive link-integrity optimization, PCIe retimers, and related support, licensing, and royalty services, targeting hyperscalers, OEMs, ODMs, optical-module makers, enterprise, and high-performance computing (HPC) customers.
Recent filings show Q4 2023 revenue of roughly $12.5 million, an 18 % year-over-year increase driven by rising demand for 400 Gbps Ethernet and PCIe 5.0/6.0 interconnects in AI-focused data centers. The company reported a cash balance of $30 million, giving it runway to fund its next-generation PAM4 and SerDes development. Macro-level, the sector is buoyed by a projected 12 % CAGR in global data-center bandwidth spending through 2028, while supply-chain tightening on advanced silicon nodes adds pricing power for niche high-speed IP licensors.
For a deeper dive into Credo’s financials and valuation multiples, consult ValueRay’s analyst overview.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (212.0m TTM) > 0 and > 6% of Revenue (6% = 47.8m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 14.60pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 138.6% (prev 199.0%; Δ -60.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 177.9m <= Net Income 212.0m (YES >=105%, WARN >=100%) |
| Net Debt (-554.8m) to EBITDA (221.9m) ratio: -2.50 <= 3.0 (WARN <= 3.5) |
| Current Ratio 8.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (185.5m) change vs 12m ago 11.40% (target <= -2.0% for YES) |
| Gross Margin 66.76% (prev 63.24%; Δ 3.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 76.26% (prev 38.46%; Δ 37.80pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -30.47 (EBITDA TTM 221.9m / Interest Expense TTM -6.87m) >= 6 (WARN >= 3) |
Altman Z'' 6.88
| (A) 0.76 = (Total Current Assets 1.24b - Total Current Liabilities 140.4m) / Total Assets 1.45b |
| (B) 0.04 = Retained Earnings (Balance) 62.9m / Total Assets 1.45b |
| (C) 0.20 = EBIT TTM 209.2m / Avg Total Assets 1.04b |
| (D) 0.38 = Book Value of Equity 62.2m / Total Liabilities 163.2m |
| Total Rating: 6.88 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.54
| 1. Piotroski 5.0pt |
| 2. FCF Yield 0.55% |
| 3. FCF Margin 18.04% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda -2.50 |
| 6. ROIC - WACC (= 8.23)% |
| 7. RoE 25.18% |
| 8. Rev. Trend 87.31% |
| 9. EPS Trend 76.36% |
What is the price of CRDO shares?
Over the past week, the price has changed by -3.53%, over one month by -11.69%, over three months by +1.33% and over the past year by +101.10%.
Is CRDO a buy, sell or hold?
- Strong Buy: 9
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CRDO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 211.6 | 46.1% |
| Analysts Target Price | 211.6 | 46.1% |
| ValueRay Target Price | 198.4 | 37% |
CRDO Fundamental Data Overview December 21, 2025
P/E Trailing = 129.4224
P/E Forward = 61.3497
P/S = 34.0627
P/B = 21.0861
Beta = 2.633
Revenue TTM = 796.1m USD
EBIT TTM = 209.2m USD
EBITDA TTM = 221.9m USD
Long Term Debt = 16.4m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 3.34m USD (from shortTermDebt, last fiscal year)
Debt = 12.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -554.8m USD (from netDebt column, last quarter)
Enterprise Value = 26.32b USD (27.12b + Debt 12.8m - CCE 813.6m)
Interest Coverage Ratio = -30.47 (Ebit TTM 209.2m / Interest Expense TTM -6.87m)
FCF Yield = 0.55% (FCF TTM 143.6m / Enterprise Value 26.32b)
FCF Margin = 18.04% (FCF TTM 143.6m / Revenue TTM 796.1m)
Net Margin = 26.63% (Net Income TTM 212.0m / Revenue TTM 796.1m)
Gross Margin = 66.76% ((Revenue TTM 796.1m - Cost of Revenue TTM 264.6m) / Revenue TTM)
Gross Margin QoQ = 67.55% (prev 67.41%)
Tobins Q-Ratio = 18.16 (Enterprise Value 26.32b / Total Assets 1.45b)
Interest Expense / Debt = 13.29% (Interest Expense 1.70m / Debt 12.8m)
Taxrate = 1.25% (1.05m / 83.7m)
NOPAT = 206.6m (EBIT 209.2m * (1 - 1.25%))
Current Ratio = 8.86 (Total Current Assets 1.24b / Total Current Liabilities 140.4m)
Debt / Equity = 0.01 (Debt 12.8m / totalStockholderEquity, last quarter 1.29b)
Debt / EBITDA = -2.50 (Net Debt -554.8m / EBITDA 221.9m)
Debt / FCF = -3.86 (Net Debt -554.8m / FCF TTM 143.6m)
Total Stockholder Equity = 841.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.63% (Net Income 212.0m / Total Assets 1.45b)
RoE = 25.18% (Net Income TTM 212.0m / Total Stockholder Equity 841.8m)
RoCE = 24.38% (EBIT 209.2m / Capital Employed (Equity 841.8m + L.T.Debt 16.4m))
RoIC = 24.54% (NOPAT 206.6m / Invested Capital 841.8m)
WACC = 16.31% (E(27.12b)/V(27.13b) * Re(16.31%) + D(12.8m)/V(27.13b) * Rd(13.29%) * (1-Tc(0.01)))
Discount Rate = 16.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 10.96%
[DCF Debug] Terminal Value 42.71% ; FCFE base≈143.6m ; Y1≈94.3m ; Y5≈43.1m
Fair Price DCF = 2.03 (DCF Value 367.0m / Shares Outstanding 180.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 76.36 | EPS CAGR: 128.9% | SUE: 3.17 | # QB: 5
Revenue Correlation: 87.31 | Revenue CAGR: 76.55% | SUE: 2.97 | # QB: 5
EPS next Quarter (2026-01-31): EPS=0.77 | Chg30d=+0.265 | Revisions Net=+11 | Analysts=12
EPS current Year (2026-04-30): EPS=2.78 | Chg30d=+0.704 | Revisions Net=+12 | Growth EPS=+297.1% | Growth Revenue=+173.0%
EPS next Year (2027-04-30): EPS=3.73 | Chg30d=+1.133 | Revisions Net=+12 | Growth EPS=+34.0% | Growth Revenue=+40.1%
Additional Sources for CRDO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle